Angiotensin converting enzyme gene (I/D) polymorphism and nonalcoholic fatty liver disease

Abstract

Keywords

• -

Angiotensin converting enzyme gene (I/D) polymorphism and nonalcoholic fatty liver disease

Abstract

-

Keywords

• -

References

1. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic ste- atohepatitis: summary of an AASLD single topic confer- ence. Hepatology 2003;37:1202-19.
2. Bedossa P, Houglum K, Trautwein C. Stimulation of colla- gen alfa 1 gene expression is associated with lipid peroxi- dation in hepatocellular injury: a link to tissue fibrozis? Hepatology 1994;19:1262.
3. Marshall RP, McAnulty RJ, Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 2000; 161: 1999-2004.
4. Rigat B, Hubert C, Alhenc-Gelas F, Corvol P, Soubrier F. An insertion/ deletion polymorphism in angiotensin con- verting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-6.
5. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D. Deletion polymorphism in the gene for angio- tensin converting enzyme is a potent risk factor for myo- cardial infarction. Nature 1992; 359:641-4.
6. Hitoshi Y, Junichi Y, Yasuhide I. Inhibition of renin-angio- tensin system attenuates liver enzyme-altered preneo- plastic lesions and fibrozis development in rats. Journal of Hepatology 2002; 37: 22-30.
7. Francesco P, Roberto C, Saverio I. Relationship between angiotensin-converting enzyme gene polymorphism and ınsulin resistance in never-treated hypertensive patients. J Clin Endocrinol Metab 2001;86:172-8.
8. Dixon JB, Bhethal PS, O’Brein PE. Nonalcoholic fatty liver disease predictors of nonalcoholic steatohepatitis and liver fibrosis in the severly obese. Gastroenterology 2001;121:91-100.

9. Brunt EM, Janey CG, Bisceglie AM. Nonalcoholic steato- hepatitis: a proposal for grading and staging the histo- logical lesions. Am J Gastroenterol 1999;94:2467.
10. Marchesini G, Forlani G NASH. From liver disease to metabolic disorders and back to clinical hepatology. Hepatology 2002;35:497-9.
11. Savaş C. Pathogenesis of hepatic fibrosis. Turkiye Klinikleri J Int Med Sci 2005; 1:5-10.
12. Ruiz-Ortega M, Ruperez M, Esteban V, Egido J. Molecular mechanisms of angiotensin II-induced vascular injury. Curr hypertens Rep 2003; 5:73-9.
13. Zingone A, Dominijanni A, Mele E: Deletion polymorphism in the gene for angiotensin-converting enzyme is asso- ciated with elevated fasting blood glucose levels. Hum Genet 1994;94:207-9.
14. Bataller R, Gines P, Nicolos JM, Gorbig MN, Garcia-Ramallo E, Gasul X. Angiotensin II induces contraction and prolif- eration of human hepatic stellate cels. Gastroenterolgy 2000;118:1149-1152.
15. Bataller R, Gines P, Nicolas JM, et al. Angiotensin II in- duces cantraction and proliferation of human hepatic stellate cells. Gastroenterology 2000;118:1153-6.
16. Baudin B. New aspects on angiotensin converting enzyme: from gene to disease. Clin Chem Lab Med 2002; 40:256- 65.
17. Osei K, Rhinesmith S, Gaillard T, Schuster D. Impaired insulin sensitivity, insulin secretion, and glucose effec- tiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care 2004; 27:1439-46.
18. Rojo-Martinez G, Esteva I, de Adana SR, et al. Patterns of insulin resistance in the general population of southeast Spain. Diabetes Res Clin Pract 2004;65:247-56.
19. Yoo KH. Thornhill BA, Wolstenholme JT, Chevaller RL. Tissue specific regulation of growthfactors and clusterin by angiotensin II. Am J Hypertens 1998;11:715-22.
20. ereshchenko SN, Demidova IV, Kobalava ZhD, Moiseev VS: Polymorphism of the ACE gene, structural-functional state of the left ventricle in patients with post-infarc- tion cardiac failure and effects of the ACE-inhibitor Perindopril. Ter Arkh 2002;74:56-8.